US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (265)
  • Diseases & Conditions (4080)
  • Drug Delivery (287)
  • Therapeutic Area (7340)
  • Vaccines (725)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
OncoMed Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' OncoMed Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Glenmark Generics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Glenmark Generics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Glenmark Generics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Glenmark Generics, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Moberg Derma AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Moberg Derma AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
NRT Smoking Cessation Aids - Germany
9/4/2014 | published by: Euromonitor International
... 6% between 2011 and 2012, with a further decline in 2013. This trend can be mainly attributed to the government’s efforts over the review period in terms of public health campaigns and new regulations to ...  |  read more...
USD 900
Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Novartis Vaccines and Diagnostics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Barr Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Barr Laboratories, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Onyx Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Onyx Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
BioCryst Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' BioCryst Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541711
8/26/2014 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.) to reach ...  |  read more...
USD 1,995
Scientific Research and Development (R&D) Industry, in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541710
8/26/2014 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics Industry (U.S.) to reach ...  |  read more...
USD 1,995
Discovery Stage Partnering Terms and Agreements
9/1/2014 | published by: Current Partnering
... by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right ...  |  read more...
USD 3,295
Just the Berries Ltd.: Ingredients - Company Profile & SWOT Report
9/4/2014 | published by: Canadean Ltd
... its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key employees as well as company locations and subsidiaries. Summary This report is a crucial ...  |  read more...
USD 125
OTC Medications in Australia (2014) – Market Sizes
9/2/2014 | published by: Mintel - Snapshots
... products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Australia is given in AUD with a minimum of ...  |  read more...
USD 600
Vitamins & Minerals in Australia (2014) – Market Sizes
9/2/2014 | published by: Mintel - Snapshots
... but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Australia is given in AUD with a minimum of five years' historical ...  |  read more...
USD 600
454 Life Sciences - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' 454 Life Sciences Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Argos Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Argos Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
IPC The Hospitalist Company, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' IPC The Hospitalist Company, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Medivir AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Medivir AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Lupin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Lupin Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Sangamo BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sangamo BioSciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Sanofi Pasteur SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sanofi Pasteur SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Alnylam Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Alnylam Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
MediGene AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' MediGene AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Bayer HealthCare Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer HealthCare Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10